Kotak Healthcare Fund
Kotak Mahindra Mutual Fund · FM: Abhishek Bisen, Dhananjay Tikariha · INF174KA1PZ7 · Direct
NAV ₹18.01 AUM ₹682 Cr as of 22 Sep 2026
Portfolio as of Jul 2026 · Last Update: 16-Aug-2026 05:01 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.5% | +2.8% | +10.0% | +31.0% | +28.0% | — | — | 4/234 | 1.04% |
Equity allocation
98.73%
Non-equity allocation (combined)
1.27%
All Equity Holdings (32) as of Jul 2026
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD. | 101.5 | 14.88% | — |
| 2 | Divis Laboratories Ltd. | 56.4 | 8.26% | — |
| 3 | TORRENT PHARMACEUTICALS LTD. | 42.1 | 6.16% | — |
| 4 | Max Healthcare Institute Ltd. | 35.1 | 5.15% | — |
| 5 | Ami Organics Ltd | 29.5 | 4.32% | — |
| 6 | Cipla Ltd. | 29.5 | 4.32% | — |
| 7 | PARK MEDI WORLD LIMITED (PARK HOSPITAL) | 26.3 | 3.86% | — |
| 8 | Fortis Healthcare India Ltd | 23.6 | 3.46% | — |
| 9 | MANKIND PHARMA LTD | 22.2 | 3.26% | — |
| 10 | SAI LIFE SCIENCES LIMITED | 21.0 | 3.08% | — |
| 11 | YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD | 20.4 | 2.99% | — |
| 12 | KRISHNA INSTITUTE OF MEDICAL | 20.1 | 2.95% | — |
| 13 | Gland Pharma Limited | 18.8 | 2.75% | — |
| 14 | Laurus Labs Ltd | 18.2 | 2.66% | — |
| 15 | Apollo Hospitals Enterprise Ltd. | 17.9 | 2.63% | — |
| 16 | ANTHEM BIOSCIENCES LTD | 16.2 | 2.37% | — |
| 17 | Ajanta Pharma Ltd. | 15.6 | 2.29% | — |
| 18 | Marksans Pharma Ltd | 15.5 | 2.27% | — |
| 19 | RUBICON RESEARCH LIMITED | 14.9 | 2.18% | — |
| 20 | ORCHID PHARMA LIMITED | 12.8 | 1.88% | — |
| 21 | EMCURE PHARMACEUTICALS LIMITED | 12.7 | 1.87% | — |
| 22 | CORONA REMEDIES LIMITED | 12.6 | 1.85% | — |
| 23 | JUBILANT INGREVIA LTD. | 12.5 | 1.83% | — |
| 24 | Aurobindo Pharma Ltd. | 11.1 | 1.62% | — |
| 25 | RAINBOW CHILDRENS MEDICARE LTD | 10.7 | 1.56% | — |
| 26 | Lupin Ltd. | 9.7 | 1.42% | — |
| 27 | JUBILANT PHARMOVA LIMITED | 9.4 | 1.37% | — |
| 28 | METROPOLIS HEALTHCARE LTD. | 8.7 | 1.28% | — |
| 29 | Zydus Lifesciences Ltd. | 8.4 | 1.24% | — |
| 30 | DR.Lal Pathlabs Ltd | 8.4 | 1.23% | — |
| 31 | INNOVA CAPTABS LTD | 7.5 | 1.10% | — |
| 32 | LAXMI DENTAL LIMITED | 4.3 | 0.64% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.